Acorah Software Products - Accounts Production 16.5.460 false true 31 October 2023 1 November 2022 false 1 November 2023 31 October 2024 31 October 2024 07401488 Mrs M Al Safadi Diab Mr M S Diab Mrs M Nahas Diab Mr M S Diab iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 07401488 2023-10-31 07401488 2024-10-31 07401488 2023-11-01 2024-10-31 07401488 frs-core:ComputerEquipment 2023-11-01 2024-10-31 07401488 frs-core:ShareCapital 2024-10-31 07401488 frs-core:RetainedEarningsAccumulatedLosses 2024-10-31 07401488 frs-bus:PrivateLimitedCompanyLtd 2023-11-01 2024-10-31 07401488 frs-bus:AbridgedAccounts 2023-11-01 2024-10-31 07401488 frs-bus:SmallEntities 2023-11-01 2024-10-31 07401488 frs-bus:AuditExempt-NoAccountantsReport 2023-11-01 2024-10-31 07401488 frs-bus:SmallCompaniesRegimeForAccounts 2023-11-01 2024-10-31 07401488 frs-bus:Director1 2023-11-01 2024-10-31 07401488 frs-bus:Director2 2023-11-01 2024-10-31 07401488 frs-bus:Director3 2023-11-01 2024-10-31 07401488 frs-bus:CompanySecretary1 2023-11-01 2024-10-31 07401488 frs-countries:EnglandWales 2023-11-01 2024-10-31 07401488 2022-10-31 07401488 2023-10-31 07401488 2022-11-01 2023-10-31 07401488 frs-core:ShareCapital 2023-10-31 07401488 frs-core:RetainedEarningsAccumulatedLosses 2023-10-31
Registered number: 07401488
AD Health Limited
Unaudited ABRIDGED Financial Statements
For The Year Ended 31 October 2024
Alexander Myerson & Co Limited
Alexander House
61 Rodney Street
Liverpool
Merseyside
L1 9ER
AD Health Limited
Contents
Contents

| Page
--- | ---
Abridged Balance Sheet | 1—2
Notes to the Abridged Financial Statements | 3—4

Page 1
AD Health Limited
Abridged Balance Sheet
As At 31 October 2024
Abridged Balance Sheet
Registered number: 07401488

| 2024 | 2023
--- | --- | ---
| Notes | £ | £ | £ | £
FIXED ASSETS
Tangible Assets | 4 |  | 391 |  | -
|  |  | 391 |  | -
CURRENT ASSETS
Stocks |  | 30,000 |  | 29,367 |
Debtors |  | 102,766 |  | 152,280 |
Cash at bank and in hand |  | 38,418 |  | 12,018 |
|  | 171,184 |  | 193,665 |
Creditors: Amounts Falling Due Within One Year |  | (148,435 ) |  | (150,565 ) |
NET CURRENT ASSETS (LIABILITIES) |  |  | 22,749 |  | 43,100
TOTAL ASSETS LESS CURRENT LIABILITIES |  |  | 23,140 |  | 43,100
NET ASSETS |  |  | 23,140 |  | 43,100
CAPITAL AND RESERVES
Called up share capital | 5 |  | 1,000 |  | 1,000
Profit and Loss Account |  |  | 22,140 |  | 42,100
SHAREHOLDERS' FUNDS |  |  | 23,140 |  | 43,100

Page 1
Page 2
AD Health Limited
Abridged Balance Sheet (continued)
As At 31 October 2024
For the year ending 31 October 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
All of the company's members have consented to the preparation of an Abridged Profit and Loss Account and an Abridged Balance Sheet for the year end 31 October 2024 in accordance with section 444(2A) of the Companies Act 2006.
On behalf of the board

Mr M S Diab Director
24 October 2025

The notes on pages 3 to 4 form part of these financial statements.
Page 2
Page 3
AD Health Limited
Notes to the Abridged Financial Statements
For The Year Ended 31 October 2024
Notes to the Abridged Financial Statements
1. General Information
AD Health Limited is a private company, limited by shares, incorporated in England & Wales, registered number 07401488 . The registered office is 61 Rodney Street, Liverpool, L1 9ER.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes.
2.3. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:

Computer Equipment | 33% reducing

2.4. Stocks and Work in Progress
Stocks and work in progress are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow-moving stocks.
2.5. Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible timing differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.
Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors. The measurement of deferred tax liabilities and assets reflect the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities.
Current and deferred tax are recognised in profit or loss for the year, except when they relate to items that are recognised in other comprehensive income or directly in equity, in which case current and deferred tax are recognised in other comprehensive income or directly in equity respectively.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 18 (2023: 17)
18 17
Page 3
Page 4
AD Health Limited
Notes to the Abridged Financial Statements (continued)
For The Year Ended 31 October 2024
4. Tangible Assets

| Total
--- | ---
| £
Cost
As at 1 November 2023 | -
Additions | 583
As at 31 October 2024 | 583
Depreciation
As at 1 November 2023 | -
Provided during the period | 192
As at 31 October 2024 | 192
Net Book Value
As at 31 October 2024 | 391
As at 1 November 2023 | -

5. Share Capital

| 2024 |  | 2023
--- | --- | --- | ---
| £ |  | £
Allotted, Called up and fully paid | 1,000 |  | 1,000

Page 4